Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nuvo Pharmaceuticals Inc NRIFF


Primary Symbol: MRVFF

Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.


OTCQX:MRVFF - Post by User

Bullboard Posts
Post by blackascanbeon Aug 26, 2010 12:33pm
389 Views
Post# 17386236

consultant 99

consultant 99I guess you and I could argue all day and you will see the glass half empty while I see it half full. Did you ever think that Covidien is doing phase 2 trials in order to get Pennsaid gel approved for joints other than just the knees? Would a delay of 6 months not be worth that? How do you know that Pennsaid isn't selling 10's of millions of dollars worth right now? If you look at the most independent assessment of Pennsaid that we have right now, that is the one from Covidien themselves, clearly having invested at least 100 million in up front payments, sales training, and future development costs of Pennsaid gel, they see value in the Pennsaid/Nuvo franchise that goes well beyond the total market cap of Nuvo right now. You as well as most everyone else on this board is letting the current ridiculously low share price affect you emotionally. Try and keep your head and focus on what the company is doing and not what the share price is. Trust me, it will be getting alot better soon.  
Bullboard Posts